Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 41 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

10%

4 trials in Phase 3/4

Results Transparency

0%

0 of 32 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 4
4(40.0%)
N/A
4(40.0%)
Phase 2
2(20.0%)
10Total
Phase 4(4)
N/A(4)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (41)

Showing 20 of 41 trials
NCT05698316Completed

A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression

Role: lead

NCT05112445Completed

Retinal Ischemia Characterization in Diabetes - "RICHARD"

Role: lead

NCT07074782Not Yet Recruiting

Retinal Ganglion Cell Neuroprotection Under Prostaglandin Analogues

Role: lead

NCT07340372Not Yet Recruiting

Home Monitoring in eAMD Treatment

Role: lead

NCT07458516Recruiting

Longitudinal Observational Study of Diabetic Retinopathy Progression in Type 2 Diabetes Patients

Role: lead

NCT07417410Recruiting

Analysis of DR Progression to Identify Risks and Need for Treatment

Role: lead

NCT06709339Phase 4Recruiting

Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO)

Role: lead

NCT04636307Completed

Characterization of Retinal Disease Progression in Eyes With Non Proliferative Diabetic Retinopathy in Diabetes Type 2 Using Non-invasive Procedures (CHART)

Role: lead

NCT05735730Not ApplicableActive Not Recruiting

Can the Risk for AMD be Modulated?

Role: lead

NCT05581225Active Not Recruiting

Prediction of Progression of Retinal Ischemia in Diabetes

Role: lead

NCT04281186Completed

Retinal and Cognitive Dysfunction in Type 2 Diabetes

Role: collaborator

NCT03349801Active Not Recruiting

Development of Novel Clinical Endpoints in Intermediate AMD

Role: collaborator

NCT05746975Completed

Diabetic Retinopathy Classification: ETDRS 7-fields vs Widefield Imaging (ClarusDR)

Role: lead

NCT05891743Completed

Prevalence of Skin Sensitization and Dermatitis Among Epoxy-exposed Workers in the Wind Turbine Industry.

Role: collaborator

NCT04650165Completed

10-year Progression of Diabetic Retinopathy: Identification of Signs and Surrogate Outcomes

Role: lead

NCT06066021Not ApplicableCompleted

Evaluation of a Health Education Program for Type 2 Diabetes Patients

Role: lead

NCT02500862Active Not Recruiting

Characterization of Potential Biomarkers of Eye Disease and Vision

Role: lead

NCT04241536Not ApplicableCompleted

Metabolomics: A Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration

Role: lead

NCT03696810Not ApplicableCompleted

Characterization of Retinal Vascular Disease in Eyes With Mild to Moderate NPDR in Diabetes Type 2

Role: lead

NCT03010397Completed

Progression of Diabetic Retinopathy. Identification of Signs and Surrogate Outcomes

Role: lead